OCRDX | VFFSX | OCRDX / VFFSX | |
Total Expense Ratio | 1.73 | 0.01 | 17,300% |
Annual Report Gross Expense Ratio | 1.73 | 0.01 | 17,300% |
Fund Existence | 32 years | 9 years | - |
Gain YTD | 11.183 | 10.485 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.35B | 1.37T | 0% |
Annual Yield % from dividends | 0.10 | 1.18 | 9% |
Returns for 1 year | 0.44 | 17.87 | 2% |
Returns for 3 years | 18.45 | 65.99 | 28% |
Returns for 5 years | 16.08 | 89.31 | 18% |
Returns for 10 years | 26.59 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSJAX | 19.94 | 0.53 | +2.73% |
Morgan Stanley Global Endurance A | |||
NBNGX | 26.48 | 0.31 | +1.18% |
Sit Mid Cap Growth | |||
TEQSX | 13.00 | 0.12 | +0.93% |
Nuveen Emerging Markets Eq Idx Retire | |||
VSTCX | 43.32 | 0.06 | +0.14% |
Vanguard Strategic Small-Cap Equity Inv | |||
PXWIX | 35.79 | -0.10 | -0.28% |
Impax Ellevate Global Women's Ldr Instl |